A Multi-center Study to Assess the Effects of BYM338 on Skeletal Muscle in Sarcopenic Adults

NCT01601600 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

40

Enrollment

INDUSTRY

Sponsor class

Conditions

Skeletal Muscle

Interventions

DRUG: BYM338
DRUG: Placebo

Sponsor

Novartis Pharmaceuticals